# Dr. Daniel Rizzuto: CTO, Nia Therapeutics

Canonical ID: `604416f6-800b-4609-a040-295f6f8b087f`

Founder, President and CTO of Nia Therapeutics. PhD in Neuroscience from Brandeis University, postdoctoral training in Neural Engineering at Caltech. Former Director of Cognitive Neuromodulation at University of Pennsylvania. Previously held product development roles at Northstar Neuroscience, Varian Medical Systems, Swedish Neuroscience Institute, and Allen Institute for Brain Science. Co-inventor of Nia's core SNS technology.

- **Verification posture:** reported

## Current roles (2)

- [Nia Therapeutics](https://registry.deploy.report/companies/nia-therapeutics.md) Founder, President and CTO (secondary-verified)
- [Nia Therapeutics](https://registry.deploy.report/companies/nia-therapeutics.md) Founder, President and CTO (secondary-verified)

## Foundings (1)

- [Nia Therapeutics](https://registry.deploy.report/companies/nia-therapeutics.md) (cofounder) _no longer at company_

See all founders: [/founders](https://registry.deploy.report/founders.md)

## Co-founders (1)

- [Dr. Michael Kahana](https://registry.deploy.report/people/michael-kahana.md) co-founded [Nia Therapeutics](https://registry.deploy.report/companies/nia-therapeutics.md)

## Sources (1)

1. https://niatherapeutics.com/about-us


_API: GET /v1/people/daniel-rizzuto · canonical URL: /people/daniel-rizzuto_